RAP1GDS1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.3899992268307E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.50789999878265E-09 |
Normal-vs-Stage2 |
6.005800E-02 |
Normal-vs-Stage3 |
<1E-12 |
Normal-vs-Stage4 |
1.03590003242005E-09 |
Stage1-vs-Stage2 |
2.607000E-01 |
Stage1-vs-Stage3 |
1.56500000003668E-06 |
Stage1-vs-Stage4 |
2.751600E-02 |
Stage2-vs-Stage3 |
2.776400E-03 |
Stage2-vs-Stage4 |
2.735600E-02 |
Stage3-vs-Stage4 |
3.103200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
5.84821080451547E-12 |
Normal-vs-AfricanAmerican |
1.39800004905766E-09 |
Normal-vs-Asian |
1.049160E-01 |
Caucasian-vs-AfricanAmerican |
2.172400E-01 |
Caucasian-vs-Asian |
4.317800E-01 |
AfricanAmerican-vs-Asian |
1.975600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.16150430887296E-11 |
Normal-vs-Female |
3.21850324169759E-11 |
Male-vs-Female |
4.235000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
3.92409999999677E-05 |
Normal-vs-Age(41-60Yrs) |
1.08249997854415E-09 |
Normal-vs-Age(61-80Yrs) |
4.92728080558891E-12 |
Normal-vs-Age(81-100Yrs) |
3.99719999999437E-06 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.195000E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.093800E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.998600E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.976000E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.403400E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.876200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
5.923600E-02 |
Normal-vs-Grade 2 |
2.78809999532115E-08 |
Normal-vs-Grade 3 |
1.63424829224823E-12 |
Normal-vs-Grade 4 |
2.05609995695966E-09 |
Grade 1-vs-Grade 2 |
4.341200E-01 |
Grade 1-vs-Grade 3 |
3.236000E-02 |
Grade 1-vs-Grade 4 |
7.100100E-02 |
Grade 2-vs-Grade 3 |
1.401890E-03 |
Grade 2-vs-Grade 4 |
8.638800E-03 |
Grade 3-vs-Grade 4 |
5.858000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.6860000062735E-09 |
Normal-vs-ccB subtype |
1.41960000421548E-08 |
ccA subtype-vs-ccB subtype |
4.301400E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
9.69424540642194E-12 |
Normal-vs-N1 |
6.199400E-03 |
N0-vs-N1 |
4.619400E-01 |
|
|